There are a number of clinical studies that have reported a respectable diagnostic performance of CSF BACE1 activity and concentration in differentiating symptomatic Alzheimer’s disease patients from cognitively healthy controls [31,32]. This evidence concerns the gene BACE1 and Alzheimer disease.